In addition, RAB42 overexpression is significantly associated with short DFS in PAAD, CESC, LGG, GBMLGG, STAD and TGCT (Figure 2C) and poor prognosis in 11 malignancies: GBMLGG, LGG, UVM, KICH, LIHC, PAAD, ACC, UCEC, KIPAN, MESO and GBM (Figure 2D). This evidence concerns the gene RAB42 and pancreatic adenocarcinoma.